| |
| |
|
| Insider
Information: |
Quinlan Paul T |
| Relationship: |
|
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
218,403 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
218,403 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
TerraVia Holdings Inc |
TVIA |
General Counsel |
2017-03-09 |
218,403 |
|
0 |
Premium* |
|
|
Cymabay Therapeutics, Inc. |
CBAY |
|
2024-03-22 |
0 |
2023-05-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CBAY |
Cymabay Therapeutics, Inc... |
General Counsel |
• – – |
2024-03-22 |
4 |
D |
$0.00 |
$0 |
D/D |
(70,262) |
0 |
0 |
- |
|
| CBAY |
Cymabay Therapeutics, Inc... |
General Counsel |
• – – |
2024-03-13 |
4 |
OE |
$7.89 |
$329,991 |
D/D |
41,824 |
70,262 |
0 |
- |
|
| CBAY |
Cymabay Therapeutics, Inc... |
General Counsel |
• – – |
2024-01-24 |
4 |
A |
$0.00 |
$0 |
D/D |
28,438 |
28,438 |
0 |
- |
|
| CBAY |
Cymabay Therapeutics, Inc... |
General Counsel |
• – – |
2024-01-16 |
4 |
AS |
$23.58 |
$117,898 |
D/D |
(5,000) |
0 |
0 |
% |
|
| CBAY |
Cymabay Therapeutics, Inc... |
General Counsel |
• – – |
2024-01-16 |
4 |
OE |
$2.94 |
$14,700 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| CBAY |
Cymabay Therapeutics, Inc... |
General Counsel |
• – – |
2023-12-15 |
4 |
AS |
$21.98 |
$109,903 |
D/D |
(5,000) |
0 |
0 |
% |
|
| CBAY |
Cymabay Therapeutics, Inc... |
General Counsel |
• – – |
2023-12-15 |
4 |
OE |
$2.94 |
$14,700 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| CBAY |
Cymabay Therapeutics, Inc... |
General Counsel |
• – – |
2023-11-15 |
4 |
AS |
$17.38 |
$86,889 |
D/D |
(5,000) |
0 |
0 |
% |
|
| CBAY |
Cymabay Therapeutics, Inc... |
General Counsel |
• – – |
2023-11-15 |
4 |
OE |
$2.94 |
$14,700 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| CBAY |
Cymabay Therapeutics, Inc... |
General Counsel |
• – – |
2023-10-16 |
4 |
AS |
$13.76 |
$68,798 |
D/D |
(5,000) |
0 |
0 |
% |
|
| CBAY |
Cymabay Therapeutics, Inc... |
General Counsel |
• – – |
2023-10-16 |
4 |
OE |
$2.94 |
$14,700 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| CBAY |
Cymabay Therapeutics, Inc... |
General Counsel |
• – – |
2023-09-15 |
4 |
AS |
$16.87 |
$894,141 |
D/D |
(53,000) |
0 |
0 |
% |
|
| CBAY |
Cymabay Therapeutics, Inc... |
General Counsel |
• – – |
2023-09-15 |
4 |
OE |
$2.94 |
$155,820 |
D/D |
53,000 |
24,000 |
0 |
- |
|
| CBAY |
Cymabay Therapeutics, Inc... |
General Counsel |
• – – |
2023-08-15 |
4 |
AS |
$11.91 |
$59,551 |
D/D |
(5,000) |
0 |
0 |
% |
|
| CBAY |
Cymabay Therapeutics, Inc... |
General Counsel |
• – – |
2023-08-15 |
4 |
OE |
$2.94 |
$14,700 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| CBAY |
Cymabay Therapeutics, Inc... |
General Counsel |
• – – |
2023-07-14 |
4 |
AS |
$11.81 |
$59,050 |
D/D |
(5,000) |
0 |
0 |
% |
|
| CBAY |
Cymabay Therapeutics, Inc... |
General Counsel |
• – – |
2023-07-14 |
4 |
OE |
$2.94 |
$14,700 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| CBAY |
Cymabay Therapeutics, Inc... |
General Counsel |
• – – |
2023-06-30 |
4 |
AS |
$10.05 |
$50,250 |
D/D |
(5,000) |
0 |
0 |
% |
|
| CBAY |
Cymabay Therapeutics, Inc... |
General Counsel |
• – – |
2023-06-30 |
4 |
OE |
$2.94 |
$14,700 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| CBAY |
Cymabay Therapeutics, Inc... |
General Counsel |
• – – |
2023-05-15 |
4 |
AS |
$10.37 |
$51,831 |
D/D |
(5,000) |
0 |
0 |
% |
|
| CBAY |
Cymabay Therapeutics, Inc... |
General Counsel |
• – – |
2023-05-15 |
4 |
OE |
$2.94 |
$14,700 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| TVIA |
TerraVia Holdings Inc |
General Counsel |
• – – |
2017-03-09 |
4 |
AS |
$0.81 |
$20,233 |
D/D |
(25,000) |
218,403 |
0 |
- |
|
| TVIA |
TerraVia Holdings Inc |
General Counsel |
• – – |
2017-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
123,000 |
243,403 |
0 |
- |
|
| TVIA |
TerraVia Holdings Inc |
General Counsel |
• – – |
2016-10-14 |
4 |
AS |
$2.55 |
$25,528 |
D/D |
(10,000) |
120,403 |
0 |
- |
|
| TVIA |
TerraVia Holdings Inc |
General Counsel |
• – – |
2016-09-16 |
4 |
AS |
$2.60 |
$8,127 |
D/D |
(3,124) |
130,528 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
